pharma · Melanoma · Multiple Myeloma · RNA
Atrium Therapeutics
Atrium Therapeutics trial registry — 31 ClinicalTrials.gov studies with program phase, status, and indication context.
10578 Science Center Dr, Suite 125, San Diego, California 92121, US HQ
2026 Founded
46 Employees
Public company Type
RNA · NYSE Ticker
Company details
- Status
- Public
- HQ
- 10578 Science Center Dr, Suite 125, San Diego, California 92121, US
- Founded
- 2026
- Employees
- 46
- Programs
- 31
- Drugs
- 33
- Patents
- 37
Atrium Therapeutics clinical trials
Registry index of 31 ClinicalTrials.gov studies linked to Atrium Therapeutics programs — each row shows trial ID, program name, phase, status, and indication.
Atrium Therapeutics trial registry — 31 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Atrium Therapeutics.
-
Rivastigmine — Approved
Clinical update -
Phenoxybenzamine — Approved
Clinical update -
Novel Supplement Based Therapy — Phase 1
Clinical update -
Metformin Hydrochloride ER — Phase 2
Clinical update -
High Dose Vitamin D — Unknown
Clinical update -
anastrozole — Phase 2
Clinical update -
Abciximab local infusion — Unknown
Clinical update -
Resveratrol, curcumin — Unknown
Clinical update